Early researches have revealed that circular RNA (circRNA) had the potential of biomarkers and could affect tumor progression through regulatory networks. However, few research focused on the function of circRNA in lung adenocarcinoma and the regulation mechanism of competitive endogenous RNA. In present study, through differential expression analysis, 10 circRNAs, 98 miRNAs(microRNA) and 2497 mRNAs were screened. Based on the 10 circRNAs and related databases, a competitive endogenous RNA regulatory network (ceRNA network) containing 7 circRNAs, 13 miRNAs and 147 mRNAs was constructed. KEGG and GO analysis suggested that 147 mRNAs were obviously enriched in biological pathway related to LUAD. By constructing a PPI network, 12 hub genes were identified by MCODE. The result of survival analysis showed that 10 hub genes (BIRC5, MKI67, CENPF, RRM2, BUB1, MELK, CEP55, CDK1, NEK2, TOP2A) were significantly related to the survival of LUAD. We randomly divided 483 clinical data into two parts: train set and validation set. The train set was used for Cox regression analysis, 3 prognostic factors (stage, T, CDK1) were screened. The nomogram model was constructed based on stage, T and CDK1. The model was evaluated by ROC curve, calibration chart, Kaplan-Meier (KM) curve and validation set data. The results indicated that the model has good accuracy. Our study elucidated the regulatory mechanism of circRNA in lung adenocarcinoma, and the nomogram model also provided insight for the clinical analysis of lung adenocarcinoma.
Citation: Pingping Song, Jing Chen, Xu Zhang, Xiaofeng Yin. Construction of competitive endogenous RNA network related to circular RNA and prognostic nomogram model in lung adenocarcinoma[J]. Mathematical Biosciences and Engineering, 2021, 18(6): 9806-9821. doi: 10.3934/mbe.2021481
[1] | Cheng-Cheng Zhu, Jiang Zhu . Spread trend of COVID-19 epidemic outbreak in China: using exponential attractor method in a spatial heterogeneous SEIQR model. Mathematical Biosciences and Engineering, 2020, 17(4): 3062-3087. doi: 10.3934/mbe.2020174 |
[2] | Cheng-Cheng Zhu, Jiang Zhu, Xiao-Lan Liu . Influence of spatial heterogeneous environment on long-term dynamics of a reaction-diffusion SVIR epidemic model with relaps. Mathematical Biosciences and Engineering, 2019, 16(5): 5897-5922. doi: 10.3934/mbe.2019295 |
[3] | Shingo Iwami, Shinji Nakaoka, Yasuhiro Takeuchi . Mathematical analysis of a HIV model with frequency dependence and viral diversity. Mathematical Biosciences and Engineering, 2008, 5(3): 457-476. doi: 10.3934/mbe.2008.5.457 |
[4] | Xiaoqing Wu, Yinghui Shan, Jianguo Gao . A note on advection-diffusion cholera model with bacterial hyperinfectivity. Mathematical Biosciences and Engineering, 2020, 17(6): 7398-7410. doi: 10.3934/mbe.2020378 |
[5] | Jinhu Xu . Dynamic analysis of a cytokine-enhanced viral infection model with infection age. Mathematical Biosciences and Engineering, 2023, 20(5): 8666-8684. doi: 10.3934/mbe.2023380 |
[6] | Kazuo Yamazaki, Xueying Wang . Global stability and uniform persistence of the reaction-convection-diffusion cholera epidemic model. Mathematical Biosciences and Engineering, 2017, 14(2): 559-579. doi: 10.3934/mbe.2017033 |
[7] | Yongli Cai, Yun Kang, Weiming Wang . Global stability of the steady states of an epidemic model incorporating intervention strategies. Mathematical Biosciences and Engineering, 2017, 14(5&6): 1071-1089. doi: 10.3934/mbe.2017056 |
[8] | Pengyan Liu, Hong-Xu Li . Global behavior of a multi-group SEIR epidemic model with age structure and spatial diffusion. Mathematical Biosciences and Engineering, 2020, 17(6): 7248-7273. doi: 10.3934/mbe.2020372 |
[9] | Xiaohong Tian, Rui Xu, Jiazhe Lin . Mathematical analysis of an age-structured HIV-1 infection model with CTL immune response. Mathematical Biosciences and Engineering, 2019, 16(6): 7850-7882. doi: 10.3934/mbe.2019395 |
[10] | Wenzhang Huang, Maoan Han, Kaiyu Liu . Dynamics of an SIS reaction-diffusion epidemic model for disease transmission. Mathematical Biosciences and Engineering, 2010, 7(1): 51-66. doi: 10.3934/mbe.2010.7.51 |
Early researches have revealed that circular RNA (circRNA) had the potential of biomarkers and could affect tumor progression through regulatory networks. However, few research focused on the function of circRNA in lung adenocarcinoma and the regulation mechanism of competitive endogenous RNA. In present study, through differential expression analysis, 10 circRNAs, 98 miRNAs(microRNA) and 2497 mRNAs were screened. Based on the 10 circRNAs and related databases, a competitive endogenous RNA regulatory network (ceRNA network) containing 7 circRNAs, 13 miRNAs and 147 mRNAs was constructed. KEGG and GO analysis suggested that 147 mRNAs were obviously enriched in biological pathway related to LUAD. By constructing a PPI network, 12 hub genes were identified by MCODE. The result of survival analysis showed that 10 hub genes (BIRC5, MKI67, CENPF, RRM2, BUB1, MELK, CEP55, CDK1, NEK2, TOP2A) were significantly related to the survival of LUAD. We randomly divided 483 clinical data into two parts: train set and validation set. The train set was used for Cox regression analysis, 3 prognostic factors (stage, T, CDK1) were screened. The nomogram model was constructed based on stage, T and CDK1. The model was evaluated by ROC curve, calibration chart, Kaplan-Meier (KM) curve and validation set data. The results indicated that the model has good accuracy. Our study elucidated the regulatory mechanism of circRNA in lung adenocarcinoma, and the nomogram model also provided insight for the clinical analysis of lung adenocarcinoma.
HIV spreads through either cell-free viral infection or direct transmission from infected to healthy cells (cell-to-cell infection) [1]. It is reported that more than 50% of viral infection is caused by the cell-to-cell infection [2]. Cell-to-cell infection can occur when infected cells encounter healthy cells and form viral synapse [3]. Recently, applying reaction-diffusion equations to model viral dynamics with cell-to-cell infection have been received attentions (see, e.g., [4,5,6]). Ren et al. [5] proposed the following reaction-diffusion equation model with cell-to-cell infection:
∂T(t,x)∂t=∇⋅(d1(x)∇T)+λ(x)−β1(x)TT∗−β2(x)TV−d(x)T, t>0, x∈Ω,∂T∗(t,x)∂t=∇⋅(d2(x)∇T∗)+β1(x)TT∗+β2(x)TV−r(x)T∗, t>0, x∈Ω,∂V(t,x)∂t=∇⋅(d3(x)∇V)+N(x)T∗−e(x)V, t>0, x∈Ω,T(0,x)=T0(x)>0, T∗(0,x)=T∗0(x)≥0, V(0,x)=V0(x)≥0, x∈Ω. | (1.1) |
In the model (1.1), T(t,x), T∗(t,x) and V(t,x) denote densities of healthy cells, infected cells and virus at time t and location x, respectively. The detailed biological meanings of parameters for the model (1.1) can be found in [5]. The well-posedness of the classical solutions for the model (1.1) have been studied. The model (1.1) admits a basic reproduction number R0, which is defined by the spectral radius of the next generation operator [5]. The model (1.1) defines a solution semiflow Ψ(t), which has a global attractor. The model (1.1) admits a unique virus-free steady state E0=(T0(x),0,0), which is globally attractive if R0<1. If R0>1, the model (1.1) admits at least one infection steady state and virus is uniformly persistent [5].
It is a challenging problem to consider the global stability of E0 in the critical case of R0=1. In [6], Wang et al. studied global stability analysis in the critical case by establishing Lyapunov functions. Unfortunately, the method can not be applied for the model consisting of two or more equations with diffusion terms, which was left it as an open problem.
Adopting the idea in [7,8,9], the present study is devoted to solving this open problem and shows that E0 is globally asymptotically stable when R0=1 for the model (1.2). For simplicity, in the following, we assume that the diffusion rates d1(x), d2(x) and d3(x) are positive constants. That is, we consider the following model
∂T(t,x)∂t=d1ΔT+λ(x)−β1(x)TT∗−β2(x)TV−d(x)T, t>0, x∈Ω,∂T∗(t,x)∂t=d2ΔT∗+β1(x)TT∗+β2(x)TV−r(x)T∗, t>0, x∈Ω,∂V(t,x)∂t=d3ΔV+N(x)T∗−e(x)V, t>0, x∈Ω,T(0,x)=T0(x)>0, T∗(0,x)=T∗0(x)≥0, V(0,x)=V0(x)≥0, x∈Ω, | (1.2) |
with the boundary conditions:
∂T(t,x)∂ν=∂T∗(t,x)∂ν=∂V(t,x)∂ν=0, t>0, x∈∂Ω, | (1.3) |
where Ω is the spatial domain and ν is the outward normal to ∂Ω. We assume that all the location-dependent parameters are continuous, strictly positive and uniformly bounded functions on ¯Ω.
Let Y=C(¯Ω,R3) with the supremum norm ∥⋅∥Y, Y+=C(¯Ω,R3+). Then (Y,Y+) is an ordered Banach space. Let T be the semigroup for the system:
∂T∗(t,x)∂t=d2ΔT∗+β1(x)T0(x)T∗+β2(x)T0(x)V−r(x)T∗,∂V(t,x)∂t=d3ΔV+N(x)T∗−e(x)V, |
where T0(x) is the solution of the elliptic problem d1ΔT+λ(x)−d(x)T=0 under the boundary conditions (1.3). Then T has the generator
˜A=(d2Δ+β1(x)T0(x)−r(x)β2(x)T0(x)N(x)d3Δ−e(x)). |
Let us define the exponential growth bound of T as
¯ω=¯ω(T):=limt→+∞ln‖T‖t, |
and define the spectral bound of ˜A by
s(˜A):=sup{Reλ,λ∈σ(˜A)}. |
Theorem 2.1. If R0=1, E0 of the model (1.2) is globally asymptotically stable.
Proof. We first show the local asymptotic stability of E0 of the model (1.2). Suppose ζ>0 and let v0=(T0,T∗0,V0) with ‖v0−E0‖≤ζ. Define m1(t,x)=T(t,x)T0(x)−1 and p(t)=maxx∈¯Ω{m1(t,x),0}. According to d1ΔT0(x)+λ(x)−d(x)T0(x)=0, we have
∂m1∂t−d1Δm1−2d1∇T0(x)∇m1T0(x)+λ(x)T0(x)m1=−β1(x)TT∗T0(x)−β2(x)TVT0(x). |
Let ˜T1(t) be the positive semigroup generated by
d1Δ+2d1∇T0(x)∇T0(x)−λ(x)T0(x) |
associated with (1.3) (see Theorem 4.4.3 in [10]). From Theorem 4.4.3 in [10], we can find q>0 such that ‖˜T1(t)‖≤M1e−qt for some M1>0. Hence, one gets
m1(⋅,t)=˜T1(t)m10−∫∞0˜T1(t−s)[β1(⋅)T(⋅,s)T∗(⋅,s)T0(⋅)+β2(⋅)T(⋅,s)V(⋅,s)T0(⋅)]ds, |
where m10=T0T0(x)−1. In view of the positivity of ˜T1(t), it follows that
p(t)=maxx∈¯Ω{ω1(t,x),0}=maxx∈¯Ω{˜T1(t)m10−∫∞0˜T1(t−s)[β1(⋅)T(⋅,s)T∗(⋅,s)T0(⋅)+β2(⋅)T(⋅,s)V(⋅,s)T0(⋅)]ds,0}≤maxx∈¯Ω{˜T1(t)m10,0}≤‖˜T1(t)m10‖≤M1e−qt‖T0T0(x)−1‖≤ζM1e−qtTm, |
where Tm=minx∈¯Ω{T0(x)}. Note that (T∗,V) satisfies
∂T∗(t,x)∂t=d2ΔT∗+β1(x)T0(x)T∗+β2(x)T0(x)V−r(x)T∗ +β1(x)T0(x)(TT0(x)−1)T∗+β2(x)T0(x)(TT0(x)−1)V,∂V(t,x)∂t=d3ΔV+N(x)T∗−e(x)V. |
It then follows that
(T∗(⋅,t)V(⋅,t))=T(t)(T∗0V0) |
+∫∞0T(t−s)(β1(⋅)T0(⋅)(T(⋅,s)T0(⋅)−1)T∗(⋅,s)+β2(⋅)T0(⋅)(T(⋅,s)T0(⋅)−1)V(⋅,s)0)ds. |
From Theorem 3.5 in [11], we have that s(˜A)=sup{Reλ,λ∈σ(˜A)} has the same sign as R0−1. If R0=1, then s(˜A)=0. Then we easily verify all the conditions of Proposition 4.15 in [12]. It follows from R0=1 and Proposition 4.15 in [12] that we can find M1>0 such that ‖T(t)‖≤M1 for t≥0, where M1 can be chosen as large as needed in the sequel. Since p(s)≤ζM1e−qsTm, one gets
max{‖T∗(⋅,t)‖,‖V(⋅,t)‖}≤M1max{‖T∗0‖,‖V0‖} +M1(‖β1‖+‖β2‖)‖T0‖∫∞0p(s)max{‖T∗(s)‖,‖V(s)‖}ds≤M1ζ+M2ζ∫∞0e−qsmax{‖T∗(s)‖,‖V(s)‖}ds, |
where
M2=M21(‖β1‖+‖β2‖)‖T0‖Tm. |
By using Gronwall's inequality, we get
max{‖T∗(⋅,t)‖,‖V(⋅,t)‖}≤M1ζe∫∞0ζM2e−qsds≤M1ζeζM2q. |
Then ∂T∂t−d1ΔT>λ(x)−d(x)T−M1ζeζM2q(β1(x)+β2(x))T. Let ˆu1 be the solution of the system:
∂ˆu1(t,x)∂t=d1Δˆu1+λ(x)−d(x)ˆu1−M1ζeζM2q(β1(x)+β2(x))ˆu1, x∈Ω, t>0,∂ˆu1(t,x)∂ν=0, x∈∂Ω, t>0,ˆu1(x,0)=T0, x∈¯Ω. | (2.1) |
Then T(t,x)≥ˆu1(t,x) for x∈¯Ω and t≥0. Let Tζ(x) be the positive steady state of the model (2.1) and ˆm(t,x)=ˆu1(t,x)−Tζ(x). Then ˆm(t,x) satisfies
∂ˆm(t,x)∂t=d1Δˆm−[d(x)+M1ζeζM2q(β1(x)+β2(x))]ˆm, x∈Ω, t>0,∂ˆm(t,x)∂ν=0, x∈∂Ω, t>0,ˆm(x,0)=T0−Tζ(x), x∈¯Ω. |
For sufficiently large M1, from Theorem 4.4.3 in [10], we have ‖F1(t)‖≤M1e¯α0t, where ¯α0<0 is a constant and F1(t):C(¯Ω,R)→C(¯Ω,R) is the C0 semigroup of d1Δ−d(⋅) subject to (1.3) [5]. Hence, we have
ˆm(⋅,t)=F1(t)(T0−Tζ(x))−∫∞0F1(t−s)M1ζeζM2q(β1(⋅)+β2(⋅))ˆm(⋅,s)ds,‖ˆm(⋅,t)‖≤M1‖T0−Tζ(x)‖e¯α0t+∫∞0M21e¯α0(t−s)ζeζM2q(‖β1(⋅)‖+‖β2(⋅)‖)‖ˆm(⋅,s)‖ds. |
Let K=M21ζeζM2q(‖β1‖+‖β2‖). By employing Gronwall's inequality, one gets
‖ˆu1(⋅,t)−Tζ(x)‖=‖ˆm(⋅,t)‖≤M1‖T0−Tζ(x)‖eKt+¯α0t. |
Choosing ζ>0 sufficiently small such that K<−¯α02, then
‖ˆu1(⋅,t)−Tζ(x)‖≤M1‖T0−Tζ(x)‖e¯α0t/2, |
and
T(⋅,t)−T0(x)≥ˆu1(⋅,t)−ˆU(x)=ˆu1(⋅,t)−Uπ(x)+Uπ(x)−ˆU(x)≥−ζM1−(M1+1)‖Tζ(x)−T0(x)‖. |
Since p(t)≤ζM1Tm, one gets T(⋅,t)−T0(x)≤ζM1‖T0(x)‖Tm, and hence
‖T(⋅,t)−T0(x)‖=max{ζM1+(M1+1)‖Tζ(x)−T0(x)‖,ζM1‖T0(x)‖Tm}. |
From
limζ→0Tζ(x)=T0(x), |
by choosing ζ small enough, for t>0, there holds ‖T(⋅,t)−T0(x)‖, ‖T∗(⋅,t)‖, ‖V(⋅,t)‖≤ε, which implies the local asymptotic stability of E0.
By Theorem 1 in [5], the solution semiflow Ψ(t):Y+→Y+ of the model (1.2) has a global attractor Π. In the following, we prove the global attractivity of E0. Define
∂Y1={(˜T,~T∗,˜V)∈Y+:~T∗=˜V=0}. |
Claim 1. For v0=(T0,T∗0,V0)∈Π, the omega limit set ω(v0)⊂∂Y1.
Since ∂T∂t≤d1ΔT+λ(x)−d(x)T, T is a subsolution of the problem
∂ˆT(t,x)∂t=d1ΔˆT+λ(x)−d(x)ˆT, x∈Ω, t>0,∂ˆT(t,x)∂ν=0, x∈∂Ω, t>0,ˆT(x,0)=T0(x), x∈¯Ω. | (2.2) |
It is well known that model (2.2) has a unique positive steady state T0(x), which is globally attractive. This together with the comparison theorem implies that
lim supt→+∞T(t,x)≤lim supt→+∞ˆT(t,x)=T0(x), |
uniformly for x∈Ω. Since v0=(T0,T∗0,V0)∈Π, we know T0≤T0. If T∗0=V0=0, the claim easily holds. We assume that either T∗0≠0 or V0≠0. Thus one gets T∗(t,x)>0 and V(t,x)>0 for x∈¯Ω and t>0. Then T(t,x) satisfies
∂T(t,x)∂t<d1ΔT+λ(x)−d(x)T(t,x),x∈Ω, t>0,∂T(t,x)∂ν=0,x∈∂Ω, t>0,T(x,0)≤T0(x), x∈Ω. |
The comparison principle yields T(t,x)<T0(x) for x∈¯Ω and t>0. Following [7], we introduce
h(t,v0):=inf{˜h∈R:T∗(⋅,t)≤˜hϕ2,V(⋅,t)≤˜hϕ3}. |
Then h(t,v0)>0 for t>0. We show that h(t,v0) is strictly decreasing. To this end, we fix t0>0, and let ¯T∗(⋅,t)=h(t0,v0)ϕ2 and ¯V(⋅,t)=h(t0,v0)ϕ3 for t≥t0. Due to T(⋅,t)<T0(x), one gets
∂¯T∗(t,x)∂t>d2Δ¯T∗+β1(x)T¯T∗+β2(x)T¯V−r(x)¯T∗,∂¯V(t,x)∂t=d3Δ¯V+N(x)¯T∗−e(x)¯V,¯T∗(x,t0)≥T∗(x,t0), ¯V(x,t0)≥V(x,t0), x∈Ω. | (2.3) |
Hence (¯T∗(t,x),¯V(t,x))≥(T∗(t,x),V(t,x)) for x∈¯Ω and t≥t0. From the model (2.3), one gets h(t0,v0)ϕ2(x)=¯T∗(t,x)>T∗(t,x) for x∈¯Ω and t>t0. Similarly, we get h(t0,v0)ϕ3(x)=¯V(t,x)>V(t,x) for x∈¯Ω and t>t0. Since t0>0 is arbitrary, h(t,v0) is strictly decreasing. Let h∗=limt→+∞h(t,v0). Then we have h∗=0. Let Q=(Q1,Q2,Q3)∈ω(v0). Then there is {tk} with tk→+∞ such that Ψ(tk)v0→Q. We get h(t,Q)=h∗ for t≥0 due to limt→+∞Ψ(t+tk)v0=Ψ(t)limt→+∞Ψ(tk)v0=Ψ(t)Q. If Q2≠0 and Q3≠0, we repeat the above discussions to illustrate that h(t,Q) is strictly decreasing, which contradicts to h(t,Q)=h∗. Thus, we have Q2=Q3=0.
Claim 2. Π={E0}.
Since {E0} is globally attractive in ∂Y1, {E0} is the only compact invariant subset of the model (1.2). From the invariance of ω(v0) and ω(v0)⊂∂Y1, one gets ω(v0)={E0}. By Lemma 3.11 in [9], we get Π={E0}.
The local asymptotic stability and global attractivity yield the global asymptotic stability of E0.
The research is supported by the NNSF of China (11901360) to W. Wang and supported by the Fundamental Research Funds for the Central Universities and the Research Funds of Renmin University of China (2019030196) to X. Lai. We also want to thank the anonymous referees for their careful reading that helped us to improve the manuscript.
The authors decare no conflicts of interest.
[1] |
F. Bray, J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre, A. Jemal, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, Ca-Cancer J. Clin., 68 (2018), 394-424. doi: 10.3322/caac.21492
![]() |
[2] |
M. Saito, K. Shiraishi, H. Kunitoh, S. Takenoshita, J. Yokota, T. Kohno, Gene aberrations for precision medicine against lung adenocarcinoma, Cancer Sci., 107 (2016), 713-720. doi: 10.1111/cas.12941
![]() |
[3] |
H. Nakamura, H. Saji, Worldwide trend of increasing primary adenocarcinoma of the lung, Surg. Today, 44 (2014), 1004-1012. doi: 10.1007/s00595-013-0636-z
![]() |
[4] | L. Osmani, F. Askin, E. Gabrielson, Q. K. Li, Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy, Semin. Cancer Biol., 68 (2017), 103-109. |
[5] |
L. Salmena, L. Poliseno, Y. Tay, L. Kats, P. Pandolfi, A ceRNA hypothesis, The Rosetta Stone of a hidden RNA language?, Cell, 146 (2011), 353-358. doi: 10.1016/j.cell.2011.07.014
![]() |
[6] |
S. Qu, X. Yang, X. Li, J. Wang, Y. Gao, R. Shang, et al., Circular RNA: A new star of noncoding RNAs, Cancer Lett., 365 (2015), 141-148. doi: 10.1016/j.canlet.2015.06.003
![]() |
[7] |
W. R. Jeck, J. A. Sorrentino, K. Wang, M. K. Slevin, C. E. Burd, J. Liu, et al., Circular RNAs are abundant, conserved, and associated with ALU repeats, RNA, 19 (2013), 141-157. doi: 10.1261/rna.035667.112
![]() |
[8] |
C. Wang, S. Tan, J. Li, W. R. Liu, Y. Peng, W. Li, CircRNAs in lung cancer-Biogenesis, function and clinical implication, Cancer Lett., 492(2020), 106-115. doi: 10.1016/j.canlet.2020.08.013
![]() |
[9] |
X. W. Li, W. H. Yang, J. Xu, Circular RNA in gastric cancer, Chin. Med. J., 133 (2020), 1868-1877. doi: 10.1097/CM9.0000000000000908
![]() |
[10] |
D. Xiong, R. He, Y. Dang, H. Wu, Z. Feng, G. Chen, The latest overview of circRNA in the progression, diagnosis, prognosis and drug resistance of hepatocellular carcinoma, Front. Oncol., 10 (2021), 608257. doi: 10.3389/fonc.2020.608257
![]() |
[11] |
Y. Li, Q. Zheng, C. Bao, S. Li, W. Guo, J. Zhao, et al., Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis, Cell Res., 25 (2015), 981-984. doi: 10.1038/cr.2015.82
![]() |
[12] |
J. Tian, X. Xi, J. Wang, J. Yu, Q. Huang, R. Ma, et al., CircRNA hsa_circ_0004585 as a potential biomarker for colorectal cancer, Cancer Manage. Res., 11 (2019), 5413-5423. doi: 10.2147/CMAR.S199436
![]() |
[13] |
Z. Li, Z. Chen, G. Hu, Y. Zhang, Y. Feng, Y. Jiang, et al., Profiling and integrated analysis of differentially expressed circRNAs as novel biomarkers for breast cancer, J. Cell. Physiol., 235 (2020), 7945-7959. doi: 10.1002/jcp.29449
![]() |
[14] |
Y. Zhong, Y. Du, X. Yang, Y. Mo, C. Fan, F. Xiong, et al., Circular RNAs function as ceRNAs to regulate and control human cancer progression, Mol. Cancer., 17 (2018), 79. doi: 10.1186/s12943-018-0827-8
![]() |
[15] |
Z. Dou, L. Gao, W. Ren, H. Zhang, X. Wang, S.Li, et al., CiRS-7 functions as a ceRNA of RAF-1/PIK3CD to promote metastatic progression of oral squamous cell carcinoma via MAPK/AKT signaling pathways, Exp. Cell Res., 396 (2020), 112290. doi: 10.1016/j.yexcr.2020.112290
![]() |
[16] |
X. Wang, X. Zhu, H. Zhang, S. Wei, Y. Chen, Y. Chen, et al., Increased circular RNA hsa_circ_0012673 acts as a sponge of miR-22 to promote lung adenocarcinoma proliferation, Biochem. Biophys. Res. Commun., 496 (2018), 1069-1075. doi: 10.1016/j.bbrc.2018.01.126
![]() |
[17] |
Z. Sun, Circular RNA hsa_circ_0001588 promotes the malignant progression of lung adenocarcinoma by modulating miR-524-3p/NACC1 signaling, Life Sci., 259(2020), 118157. doi: 10.1016/j.lfs.2020.118157
![]() |
[18] |
L. Liang, L. Zhang, J. Zhang, S. Bai, H. Fu, Identification of circRNA-miRNA-mRNA networks for exploring the fundamental mechanism in lung adenocarcinoma, Onco Targets Ther., 13 (2020), 2945-2955. doi: 10.2147/OTT.S235664
![]() |
[19] |
X. X. Liu, Y. E. Yang, X. Liu, M. Y. Zhang, R. Li, Y. H. Yin, et al., A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma, J. Transl. Med., 17 (2019), 50. doi: 10.1186/s12967-019-1800-z
![]() |
[20] |
S. Xia, J. Feng, K. Chen, Y. Ma, J. Gong, F. Cai, et al., CSCD: a database for cancer-specific circular RNAs, Nucleic Acids Res., 46 (2018), D925-D929. doi: 10.1093/nar/gkx863
![]() |
[21] |
C. H. Chou, S. Shrestha, C. D. Yang, N. W. Chang, Y. L. Lin, K. W. Liao, et al., miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions, Nucleic Acids Res., 46 (2018), D296-D302. doi: 10.1093/nar/gkx1067
![]() |
[22] |
V. Agarwal, G. W. Bell, J. W. Nam, D. P. Bartel, Predicting effective microRNA target sites in mammalian mRNAs, eLife, 4 (2015), e05005. doi: 10.7554/eLife.05005
![]() |
[23] |
P. Shannon, A. Markiel, O. Ozier, N. S. Baliga, J. T. Wang, D. Ramage, et al., Cytoscape: a software environment for integrated models of biomolecular interaction networks, Genome Res., 13 (2003), 2498-2504. doi: 10.1101/gr.1239303
![]() |
[24] |
D. W. Huang, B. T. Sherman, R. A. Lempicki, Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources, Nat. Protoc., 4 (2009), 44-57. doi: 10.1038/nprot.2008.211
![]() |
[25] |
D. W. Huang, B. T. Sherman, R. A. Lempicki, Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists, Nucleic Acids Res., 37 (2009), 1-13. doi: 10.1093/nar/gkn923
![]() |
[26] | D. Szklarczyk, A. L. Gable, D. Lyon, A. Junge, S. Wyder, J. Huerta-Cepas, et al., STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets, Nucleic Acids Res., 47 (2009), D607-D613. |
[27] | G. D. Bader, C. W. Hogue, An automated method for finding molecular complexes in large protein interaction networks, BMC Bioinf.. 4 (2003). |
[28] |
Z. Tang, C. Li, B. Kang, G. Gao, C. Li, Z. Zhang, GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses, Nucleic Acids Res., 45 (2017), W98-W102. doi: 10.1093/nar/gkx247
![]() |
[29] |
D. S. Chandrashekar, B. Bashel, S. A. H. Balasubramanya, C. J. Creighton, I. Ponce-Rodriguez, B. V. Chakravarthi, et al., UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses, Neoplasia., 19 (2017), 649-658. doi: 10.1016/j.neo.2017.05.002
![]() |
[30] |
Z. R. Zhou, W. W. Wang, Y. Li, K. R. Jin, X. Y. Wang, Z. W. Wang, et al., In-depth mining of clinical data: the construction of clinical prediction model with R, Ann. Transl. Med., 7 (2019), 796. doi: 10.21037/atm.2019.08.63
![]() |
[31] |
Y. Zhang, H. Yao, Y. Li, L. Yang, L. Zhang, J. Chen, et al., Circular RNA TADA2A promotes proliferation and migration via modulating of miR-638/KIAA0101 signal in non-small cell lung cancer, Oncol. Rep., 46 (2021), 201. doi: 10.3892/or.2021.8152
![]() |
[32] |
H. Zhao, H. Wei, J. He, D. Wang, W. Li, Y. Wang, et al., Propofol disrupts cell carcinogenesis and aerobic glycolysis by regulating circTADA2A/miR-455-3p/FOXM1 axis in lung cancer, Cell Cycle, 19 (2020), 2538-2552. doi: 10.1080/15384101.2020.1810393
![]() |
[33] | Z. Wu, M. Zheng, Y. Zhang, M. Xie, S. Tian, T. Ding, et al., Hsa_circ_0043278 functions as competitive endogenous RNA to enhance glioblastoma multiforme progression by sponging miR-638, Aging (Albany NY), 12 (2020), 21114-21128. |
[34] |
C. Liu, T. Han, Y. Shi, The decreased expression of hsa_circ_0043278 and its relationship with clinicopathological features of breast cancer, Gland Surg., 9 (2020), 2044-2053. doi: 10.21037/gs-20-825
![]() |
[35] |
F. Tian, C. T. Yu, W. D. Ye, Q. Wang, Cinnamaldehyde induces cell apoptosis mediated by a novel circular RNA hsa_circ_0043256 in non-small cell lung cancer, Biochem. Biophys. Res. Commun., 493 (2017), 1260-1266. doi: 10.1016/j.bbrc.2017.09.136
![]() |
[36] |
Q. Wang, T. Wang, Y. Hu, W. Jiang, C. Lu, W. Zheng, et al., Circ-EIF4G3 promotes the development of gastric cancer by sponging miR-335, Pathol., Res. Pract., 215 (2019), 152507. doi: 10.1016/j.prp.2019.152507
![]() |
[37] |
W. Zhang, Z. Wang, G. Cai, P. Huang, Circ_DOCK1 regulates USP11 through miR-132-3p to control colorectal cancer progression, World J. Surg. Oncol., 19 (2021), 67. doi: 10.1186/s12957-021-02173-x
![]() |
[38] | L. G. Di, C. M. Croce, miRNA profiling of cancer, Curr. Opin. Genet. Dev., 23 (2013), 3-11. |
[39] | R. Q. He, L. Gao, J. Ma, Z. Y. Li, X. H. Hu, G.Chen, Oncogenic role of miR-183-5p in lung adenocarcinoma: A comprehensive study of qPCR, in vitro experiments and bioinformatic analysis, Oncol. Rep., 40 (2018), 83-100. |
[40] |
Y. Lin, Q. Gu, Z. Sun, B. Sheng, C. Qi, B. Liu, et al., Upregulation of miR-3607 promotes lung adenocarcinoma proliferation by suppressing APC expression, Biomed. Pharmacother., 95 (2017), 497-503. doi: 10.1016/j.biopha.2017.08.052
![]() |
[41] |
Y. L. Wan, H. J. Dai, W. Liu, H. T. Ma, miR-767-3p inhibits growth and migration of lung adenocarcinoma cells by regulating CLDN18, Oncol. Res., 26(2018), 637-644. doi: 10.3727/096504017X15112639918174
![]() |
[42] |
X. Wu, T. Liu, O. Fang, W. Dong, F. Zhang, L. Leach, et al., MicroRNA-708-5p acts as a therapeutic agent against metastatic lung cancer, Oncotarget., 7(2016), 2417-2432. doi: 10.18632/oncotarget.6594
![]() |
[43] |
W. Zhou, R. Li, microRNA-605 inhibits the oncogenicity of non-small-cell lung cancer by directly targeting Forkhead Box P1, Onco Targets Ther., 12 (2019), 3765-3777. doi: 10.2147/OTT.S193675
![]() |
[44] |
Y. Wei, Y. Liao, Y. Deng, Y. Zu, B. Zhao, F. Li, MicroRNA-503 inhibits non-small cell lung cancer progression by targeting PDK1/PI3K/AKT pathway, Onco Targets Ther., 12 (2019), 9005-9016. doi: 10.2147/OTT.S213059
![]() |
[45] |
G. Fan, J. Jiao, F. Shen, Q. Ren, Q. Wang, F. Chu, Long non-coding RNA HCG11 sponging miR-522-3p inhibits the tumorigenesis of non-small cell lung cancer by upregulating SOCS5, Thorac. Cancer., 11 (2020), 2877-2886. doi: 10.1111/1759-7714.13624
![]() |
[46] |
W. Han, L. Wang, L. Zhang, Y. Wang, Y. Li, Circular RNA circ-RAD23B promotes cell growth and invasion by miR-593-3p/CCND2 and miR-653-5p/TIAM1 pathways in non-small cell lung cancer, Biochem. Biophys. Res. Commun., 510 (2019), 462-466. doi: 10.1016/j.bbrc.2019.01.131
![]() |
[47] |
J. H. Li, S. S. Sun, N. Li, P. Lv, S. Y. Xie, P. Y. Wang, MiR-205 as a promising biomarker in the diagnosis and prognosis of lung cancer, Oncotarget., 8 (2017), 91938-91949. doi: 10.18632/oncotarget.20262
![]() |
[48] |
D. B. Mendonça, J. T. Nguyen, F. Haidar, A. L. Fox, C. Ray, H. Amatullah, et al., MicroRNA-1911-3p targets mEAK-7 to suppress mTOR signaling in human lung cancer cells, Heliyon, 6 (2020), e05734. doi: 10.1016/j.heliyon.2020.e05734
![]() |
[49] |
B. R. Druliner, J. A. Fincher, B. S. Sexton, D. L. Vera, M. Roche, S. Lyle, et al., Chromatin patterns associated with lung adenocarcinoma progression, Cell Cycle, 12 (2013), 1536-43. doi: 10.4161/cc.24664
![]() |
[50] |
T. Eguchi, K. Kadota, J. Chaft, B. Evans, J. Kidd, K. S. Tan, et al., Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma, Oncotarget, 7 (2016), 35241-35256. doi: 10.18632/oncotarget.9129
![]() |
[51] |
J. Zhu, H. Ao, M. Liu, K. Cao, J. Ma, UBE2T promotes autophagy via the p53/AMPK/mTOR signaling pathway in lung adenocarcinoma, J. Transl. Med., 19 (2021), 374. doi: 10.1186/s12967-021-03056-1
![]() |
[52] |
Y. Tian, X. Tian, X. Han, Y. Chen, C. Y. Song, Y. B. Zhang, et al., Expression of ATP binding cassette E1 enhances viability and invasiveness of lung adenocarcinoma cells in vitro, Mol. Med. Rep., 14 (2016), 1345-50. doi: 10.3892/mmr.2016.5388
![]() |
[53] |
C. C. Wang, Y. L. Hsu, C. J. Chang, C. J. Wang, T. H. Hsiao, S. H. Pan, Inhibitor of DNA-binding protein 4 suppresses cancer metastasis through the regulation of epithelial mesenchymal transition in lung adenocarcinoma, Cancers, 11(2019), 2021. doi: 10.3390/cancers11122021
![]() |
![]() |
![]() |
1. | Yazhi Wu, Guangyao Tang, Changcheng Xiang, Dynamic analysis of a predator-prey state-dependent impulsive model with fear effect in which action threshold depending on the prey density and its changing rate, 2022, 19, 1551-0018, 13152, 10.3934/mbe.2022615 | |
2. | Wei Li, Tonghua Zhang, Yufei Wang, Huidong Cheng, Dynamic analysis of a plankton–herbivore state-dependent impulsive model with action threshold depending on the density and its changing rate, 2022, 107, 0924-090X, 2951, 10.1007/s11071-021-07022-w | |
3. | Sheng-qiang Zhang, Xin-zhu Meng, Asymptotic analysis of a nonlinear stochastic eco-epidemiological system with feedback control, 2022, 37, 1005-1031, 317, 10.1007/s11766-022-3631-6 | |
4. | Xinzhi Ren, Kaifa Wang, Xianning Liu, Dynamics on a degenerated reaction–diffusion Zika transmission model, 2024, 150, 08939659, 108935, 10.1016/j.aml.2023.108935 | |
5. | Liping Wu, Zhongyi Xiang, Dynamic analysis of a predator-prey impulse model with action threshold depending on the density of the predator and its rate of change, 2024, 9, 2473-6988, 10659, 10.3934/math.2024520 | |
6. | Cuifang Lv, Xiaoyan Chen, Chaoxiong Du, Global dynamics of a cytokine-enhanced viral infection model with distributed delays and optimal control analysis, 2025, 10, 2473-6988, 9493, 10.3934/math.2025438 |